Trial intelligence / Profile preview

Selegiline and Tadalafil for ED in Parkinson's Disease

NCT02225548Phase 4Unknown

Sponsor
University of South Florida
Start
Sep 2014
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of selegiline in erectile dysfunction (ED), sponsored by University of South Florida. Status: unknown.

02

Drugs

selegiline
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT02225548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02225548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call